Delic Holdings Appoints Dr. Eric Janusson As Lead Chemist
Complex Biotech Discovery Ventures Ltd., a licensed cannabis and psilocybin research laboratory, has appointed Dr. Eric Janusson as its lead chemist.
The news was released Wednesday by psychedelic wellness-focused company
Delic Holdings Inc. (CSE:DELC) (OTCQB:DELCF), which plans to acquire the laboratory.
Janusson, who specializes in real-time methods for the quantification and characterization of sensitive chemical intermediates, earned his Ph.D. in analytical chemistry at the University of Victoria in 2017.
Dr. Markus Roggen, Director of Delic Corp & Founder of CBDV, said he was excited to have Janusson on board. [Janusson] is instrumental to combine our analytical platforms with our machine learning capabilities, Roggen added.
Vertically integrated cannabis company Acreage Holdings, Inc. (CSE:ACRG) (OTC: ACRGF) and Medterra CBD, LLC are joining forces to develop a CBD-based collection of products.
The move follows the recent sale of Acreage s Florida operations to Red White & Bloom Brands, Inc. (CSE:RWB) (OTCQX:. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to:
Medterra CBD, LLC are joining forces to develop a CBD-based collection of products.
The move follows the recent sale of Acreage s Florida operations to
Red White & Bloom Brands, Inc. (CSE:RWB) (OTCQX:RWBYF) for $60 million.
The JV Deal: Under the joint venture between Acreage and Medterra,
Five Farms CBD, LLC
., Medterra s subsidiary – opted to develop CBD products under Acreage s brand, The Botanist.
Acreage agreed to license The Botanist brand to Five Farms, which will produce as well as market and sell CBD products under The Botanist brand via Medterra s e-commerce platform.
What It Means For Acreage: The partnership between Acreage s subsidiary
Cannabis stocks traded mostly in the green this week, as we got into earnings season.
“While there were a lot of companies reporting earnings, like Turning Point Brands who gave guidance of $422 million for 2021, I thought the biggest piece of data came from Pennsylvania
,” Debra Borchardt, editor-in-chief of Green Market Report, told Benzinga. “The state reported that in one year it had sold over $900 million in medical marijuana. This demonstrates the demand for cannabis in this state and bodes well for any future adult-use legalization. This is also a big number when one considers that the program has only just gotten underway.”